BVS
Bioventus Inc. · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2026-03-05
Figures on this page computed 2026-11-08 12:24 UTC
Last close
10.61USD
Market data, 2026-11-06
Except where said otherwise: 10-K for 2025, filed 2026-03-05
31.2xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001665988-26-000011
- Reported in
- USD
- computed
- 10-K for 2025, filed 2026-03-05
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001665988-26-000011
- Reported in
- USD
- 10-K for 2025, filed 2026-03-05
- 10-K for 2025, filed 2026-03-05
- 10-K for 2025, filed 2026-03-05
- 10-Q for 2025, filed 2026-11-02
- 10-K for 2025, filed 2026-03-05
- 10-Q for 2025, filed 2026-11-02
4.0%Net margin
Net Income / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001665988-26-000011
- Reported in
- USD
- 10-K for 2025, filed 2026-03-05
- 10-K for 2025, filed 2026-03-05
12.7%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001665988-26-000011
- Reported in
- USD
- 10-K for 2025, filed 2026-03-05
- 10-K for 2025, filed 2026-03-05
1.69Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001665988-26-000011
- Reported in
- USD
- 10-K for 2025, filed 2026-03-05
- 10-Q for 2025, filed 2026-11-02
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
Safety is the furthest below its sector's middle: 0.36 against 0.58 on the market's range.
- Growth12.1%75 of 100, above its sector
- Returns on capital12.3%71 of 100, above its sector
- Margins68.3%70 of 100, above its sector
- Price31.2x47 of 100, above its sector
- Safety1.6936 of 100, below its sector
- What it pays outn/anot placed
- What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.
Six questions
lens 5 of 9Six questions
3 yes of 5 answered- 1Does it earn money?yes
net margin, read above 0.
- 2Can it pay what it owes?Not known
interest coverage, read above 3. We do not hold that figure for this company.
- 3Is it bigger than five years ago?yes
rev growth 5y, read above 0.
- 4Does the profit turn into cash?yes
fcf margin, read above 0.
- 5Is it issuing shares?no
share count change yoy, read below 1.
- 6Is it priced under twenty times earnings?no
pe ratio, read below 20.
1 of these could not be answered. That is not a no: it is a figure we do not hold, and it is left as what it is.
3 of 5 questions answered yes; 1 could not be answered.
3 of 5 questions answered yes; 1 could not be answered.
Every figure in this lens
Except where said otherwise: 10-K for 2025, filed 2026-03-05
Does it earn money?4.0%
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001665988-26-000011
- Reported in
- USD
Can it pay what it owes?n/a
Not held.
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001665988-26-000011
- Reported in
- USD
Is it bigger than five years ago?12.1%
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001665988-26-000011
- Reported in
- USD
Does the profit turn into cash?12.7%
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001665988-26-000011
- Reported in
- USD
Is it issuing shares?6.8%
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001665988-26-000011
- Reported in
- USD
Is it priced under twenty times earnings?31.2x
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001665988-26-000011
- Reported in
- USD